Education
About Us
Working with TipRanks
Follow Us
SIGA Technologies Inc (SIGA)
NASDAQ:SIGA
SIGA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.95 - $12.83
Previous CloseN/A
Volume59.56K
Average Volume (3M)387.52K
Market Cap
$483.66M
Enterprise Value$438.50M
Total Cash (Recent Filing)$162.27M
Total Debt (Recent Filing)$558.65K
Price to Earnings (P/E)10.0
Beta0.91
Next Earnings
Jul 31, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 29, 2025Dividend Yield10.13%
Share Statistics
EPS (TTM)-0.01
Shares Outstanding71,441,086
10 Day Avg. Volume320,471
30 Day Avg. Volume387,519
Financial Highlights & Ratios
PEG Ratio-0.32
Price to Book (P/B)3.15
Price to Sales (P/S)0.00
P/FCF Ratio12.90
Enterprise Value/Market Cap0.91
Enterprise Value/Revenue0.72
Enterprise Value/Gross Profit5.14
Enterprise Value/Ebitda1.31
Forecast
1Y Price Target
$7.50Price Target Upside10.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
SIGA Technologies News
PremiumCompany Announcements
SIGA Technologies Holds Annual Stockholders Meeting
PremiumCompany Announcements
SIGA Technologies’ Earnings Call Highlights Growth and Stability
PremiumCompany Announcements
SIGA Technologies Reports Q1 2025 Financial Results
PremiumCompany Announcements
SIGA Technologies Appoints Gen. Keane as New Director
PremiumCompany Announcements
SIGA Technologies Reports Strong Financial Growth and Strategic ProgressOwnership Overview
1.46% Insiders
15.40% Mutual Funds
18.61% Other Institutional Investors
54.40% Public Companies and Individual Investors
SIGA FAQ
What was SIGA Technologies Inc’s price range in the past 12 months?
SIGA Technologies Inc lowest stock price was $4.95 and its highest was $12.83 in the past 12 months.
What is SIGA Technologies Inc’s market cap?
SIGA Technologies Inc’s market cap is $483.66M.
When is SIGA Technologies Inc’s upcoming earnings report date?
SIGA Technologies Inc’s upcoming earnings report date is Jul 31, 2025 which is in 16 days.
How were SIGA Technologies Inc’s earnings last quarter?
Currently, no data Available
Is SIGA Technologies Inc overvalued?
According to Wall Street analysts SIGA Technologies Inc’s price is currently Undervalued.
Does SIGA Technologies Inc pay dividends?
SIGA Technologies Inc pays a Notavailable dividend of $0.6 which represents an annual dividend yield of 10.13%. See more information on SIGA Technologies Inc dividends here
What is SIGA Technologies Inc’s EPS estimate?
SIGA Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SIGA Technologies Inc have?
SIGA Technologies Inc has 71,441,086 shares outstanding.
What happened to SIGA Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SIGA Technologies Inc?
Currently, no hedge funds are holding shares in SIGA
SIGA Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.50 (10.78% Upside)
$7.50 (10.78% Upside)
Blogger Sentiment
Bullish
SIGA Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 1.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.95%
12-Months-Change
Fundamentals
Return on Equity
25.47%
Trailing 12-Months
Asset Growth
1.61%
Trailing 12-Months
Company Description
SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Technical Analysis
Emergent Biosolutions
―
Evotec AG
―
Organogenesis Holdings
―
Aquestive Therapeutics
―
Regencell Bioscience
―